Sign in

CIK 0001069899 · Large accelerated filer

PHIBRO ANIMAL HEALTH CORP

Sign in to watch
Ticker
PAHC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
131840497
Phone
201-329-7300
Business address
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
Former names
PHILIPP BROTHERS CHEMICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-09-05 Miller Larry Lee Chief Operating Officer Sale −810 $36.49 $30K 0
2017-09-05 Miller Larry Lee Chief Operating Officer Option exercise · Option to purchase Common Stock −5,047 167,453
2017-09-05 Johnson Richard G Chief Financial Officer Option exercise +4,240 $11.83 $50K 4,240
2017-09-05 Johnson Richard G Chief Financial Officer Sale −4,240 $35.56 $151K 0
2017-09-05 Johnson Richard G Chief Financial Officer Option exercise +764 $11.83 $9K 764
2017-09-05 Johnson Richard G Chief Financial Officer Sale −764 $36.54 $28K 0
2017-09-05 Johnson Richard G Chief Financial Officer Option exercise · Option to purchase Common Stock −5,004 61,296
2017-08-21 Bendheim Daniel M Exec. VP, Corporate Strategy Option exercise +800 $11.83 $9K 800
2017-08-21 Bendheim Daniel M Exec. VP, Corporate Strategy Sale −800 $40.02 $32K 0
2017-08-21 Bendheim Daniel M Exec. VP, Corporate Strategy Option exercise · Option to purchase Common Stock −800 27,123
2017-08-17 Bendheim Daniel M Exec. VP, Corporate Strategy Option exercise +4,176 $11.83 $49K 4,176
2017-08-17 Bendheim Daniel M Exec. VP, Corporate Strategy Sale −4,176 $40.01 $167K 0
2017-08-17 Bendheim Daniel M Exec. VP, Corporate Strategy Option exercise · Option to purchase Common Stock −4,176 27,923
2017-08-16 Bendheim Daniel M Exec. VP, Corporate Strategy Option exercise +5,938 $11.83 $70K 5,938
2017-08-16 Bendheim Daniel M Exec. VP, Corporate Strategy Sale −5,938 $40.04 $238K 0
2017-08-16 Bendheim Daniel M Exec. VP, Corporate Strategy Option exercise · Option to purchase Common Stock −5,938 32,099
2017-08-15 Bendheim Daniel M Exec. VP, Corporate Strategy Option exercise +1,443 $11.83 $17K 1,443
2017-08-15 Bendheim Daniel M Exec. VP, Corporate Strategy Sale −1,443 $40.05 $58K 0
2017-08-15 Bendheim Daniel M Exec. VP, Corporate Strategy Option exercise · Option to purchase Common Stock −1,443 38,037
2017-08-14 Bendheim Daniel M Exec. VP, Corporate Strategy Option exercise +300 $11.83 $4K 300

Page 27 of 41 · 803 trades